Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Lynch

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infectionYoussif Mohammed Ali, Azam Hayat, Bayad Mawlood Saeed, et al.
Immunology|January 25, 2026
Activation of the Lectin Pathway Drives Persistent Complement Dysregulation in Long COVIDSamuel B K Keat, Priyanka Khatri, Youssif M Ali, et al.
European Journal of Immunology|August 13, 2004
Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiencyAnja Roos, Peter Garred, Manon E Wildenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2011
Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injuryWilhelm J Schwaeble, Nicholas J Lynch, James E Clark, et al.
Science Translational Medicine|June 17, 2026
Engineered antibodies bypass bacterial immune evasion to drive complement-mediated protection against lethal infectionsYoussif M Ali, Munehisa Yabuki, Chanuka H Arachchilage, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infectionYoussif Mohammed Ali, Azam Hayat, Bayad Mawlood Saeed, et al.
Immunology|January 25, 2026
Activation of the Lectin Pathway Drives Persistent Complement Dysregulation in Long COVIDSamuel B K Keat, Priyanka Khatri, Youssif M Ali, et al.
European Journal of Immunology|August 13, 2004
Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiencyAnja Roos, Peter Garred, Manon E Wildenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2011
Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injuryWilhelm J Schwaeble, Nicholas J Lynch, James E Clark, et al.
Science Translational Medicine|June 17, 2026
Engineered antibodies bypass bacterial immune evasion to drive complement-mediated protection against lethal infectionsYoussif M Ali, Munehisa Yabuki, Chanuka H Arachchilage, et al.
Pageof 3